Diabetes Care Devices And Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Diabetes is a chronic disease which is caused due to high blood glucose levels. Insulin is a hormone that is responsible for moving glucose from blood into cells which is to be stored or used for energy. The diabetic patients's body either doesn't make enough insulin or can't effectively use the insulin it. Diabetes is treated with medications where some are orally administered , while others are given as injections. Several medical devices are used to treat or monitor diabetes. For instance, blood glucose meter and continuous blood glucose monitors are used to monitor diabetes, whereas, insulin pen, insulin pump and jet injector are used to treat diabetes.

MARKET DYNAMICS

The diabetes care devices and drugs market is expected to witness growth owing to growing prevalence of diabetes and increasing incidence of obesity. Moreover, growing pharmaceutical and medical device industry in developing nations is likely to create growth opportunities in the market.

MARKET SCOPE

The "Diabetes Care Devices and Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes care devices and drugs market with detailed market segmentation by diabetes care devices, and diabetes care drugs. The diabetes care devices and drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetes care devices and drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The diabetes care devices and drugs market is segmented on the basis of diabetes care devices, and diabetes care drugs The diabetes care devices segment is divided into diabetes monitoring devices, and insulin delivery devices. Based on diabetes care drugs the market is segmented into Insulin, Oral-hypoglycaemic drugs, Non-insulin injectable drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diabetes care devices and drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes care devices and drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diabetes care devices and drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetes care devices and drugs market in these regions.

MARKET PLAYERS

The report covers key developments in the diabetes care devices and drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diabetes care devices and drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for diabetes care devices and drugs in the global market. Below mentioned is the list of few companies engaged in the diabetes care devices and drugs market.

The report also includes the profiles of key players in diabetes care devices and drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Novo Nordisk A/S
  
•   Ypsomed AG
  
•   Abbott Laboratories
  
•   Ascensia Diabetes Care Holdings AG
  
•   Eli Lilly and Company
  6. Hoffmann-La Roche Ltd
  7. Johnson & Johnson
  
•   Medtronic PLC
  
•   Becton, Dickinson and Company
  
•   Terumo Corporation
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Diabetes Care Devices And Drugs Report Scope